Phaarmasia

India Listed

Provider of used cooking oil recycling and grease trap services

Page last updated 29 Aug 2026

About Phaarmasia

Phaarmasia is a publicly listed company based in India. Provider of used cooking oil recycling and grease trap services. The company has 14 employees. Its Indian entity Phaarmasia Limited reported revenue of ₹67.16 Cr. Its focus areas include Traditional Pharmaceuticals.

Company details

Services for recycling used cooking oil, fats, oils, and grease are offered by Phaarmasia, a company operating in the environmental waste management sector. Collection and processing of these materials occur across India, with additional maintenance for grease traps and interceptors provided. Recycled oil is converted into biodiesel, and responsible disposal practices are followed. Price-matching options are available to support client needs in commercial food operations.

Headquarters India
Employees 14
Stage Public
Sectors
Healthcare
Website phaarmasia.in
Legal Name Phaarmasia Ltd.

Operational Areas

Healthcare → Traditional Health & Nutrition

Key Metrics

Market Cap
₹58.74 Cr
PHRMASI · BSE
Share Price
₹79.25
-7.85% today
Revenue
₹47.21 Cr
FY 2025-26 · +93.7% YoY
EBITDA
₹1.87 Cr
Margin 4.0%
Net Profit
−₹4.79 Cr
FY 2025-26 · -199.4% YoY
P/E (TTM)
26.8x
P/B 2.7x
ROE
-36.1%
ROCE 18.6%
Debt / Equity
0.04
Interest cover 13.2x
Employee Count
14

Associated legal entities of Phaarmasia

Phaarmasia operates through Phaarmasia Limited, a listed company (active). Its filings, financials, charges and directors are on the company page.

Legal entity	Status	Incorporated	Registered in	Revenue (FY 2026)	Employees	Directors	Company page
Phaarmasia Limited Listed CIN L24239TG1981PLC002915	Active	06 Feb 1981	Hyderabad, Telangana	₹67.2 Cr	14	8	View details

Board of directors of Phaarmasia Limited (Phaarmasia)

Phaarmasia Limited is the primary company behind Phaarmasia. The board of Phaarmasia Limited currently have 6 directors; the longest-serving is Naga Bhaskarrao Yallapragada, appointed in 2004. 9 earlier directors have ceased.

Director	Designation	Appointed	Tenure	Entity
Naga Bhaskarrao Yallapragada DIN 00019052	Whole-time director	10 Sep 2004	22 yrs 2 mo	Phaarmasia Limited
Maneesh Ramakant Sapte DIN 00020450	Director	01 Mar 2006	20 yrs 8 mo	Phaarmasia Limited
Vinay Ramakant Sapte DIN 00135085	Director	30 Apr 2009	17 yrs 6 mo	Phaarmasia Limited
Rashmi Vinay Sapte DIN 00334247	Director	14 Feb 2015	11 yrs 8 mo	Phaarmasia Limited
Pravin Mohandas Hegde DIN 01404954	Director	14 Feb 2017	9 yrs 8 mo	Phaarmasia Limited
Ajit Gopal Jamkhandikar DIN 08196191	Director	14 Aug 2018	8 yrs 3 mo	Phaarmasia Limited

IPO & Listings of Phaarmasia

Phaarmasia is a publicly listed company on the BSE with ticker symbol PHRMASI in India, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

IPO date12 Nov 1992
Listed onBSE: 523620
Listed entityPhaarmasia Ltd.
Exchange sectorHealth technology
ISININE486I01016
Share price₹80.46 (-3.07% on the day) · 2026-10-13
Market capitalisation₹54.9 Cr
Price to earnings3.1
EPS (diluted, trailing year)₹25.85
Volume (last session)480

Financials of Phaarmasia

Exchange-reported figures of Phaarmasia Limited, the listed company behind Phaarmasia (BSE: PHRMASI).

Financial Highlights

FY 2025-26 · Standalone

Revenue

₹47.21 Cr

+93.7% YoY

EBITDA

₹1.87 Cr

+192.6% YoY

Profit After Tax

−₹4.79 Cr

-199.4% YoY

Net Worth

₹22.10 Cr

+152.9% YoY

Total Assets

₹23.44 Cr

+161.3% YoY

Total Debt

₹1.12 Cr

- YoY

Revenue vs Net Profit ₹ Cr

Margin trends

Financial summary ₹ Cr

Metrics	FY 2025-26	FY 2024-25	FY 2023-24	FY 2022-23	FY 2021-22	FY 2020-21	FY 2019-20
Income statement
Revenue	47.21	24.37	30.59	27.49	11.77	16.26	19.93
Revenue growth	+93.7%	-20.3%	+11.3%	+133.6%	-27.6%	-18.4%	-
EBITDA	1.87	(2.02)	(0.84)	(1.55)	(1.74)	(0.06)	0.81
EBITDA margin	+4.0%	-8.3%	-2.8%	-5.6%	-14.8%	-0.4%	+4.1%
Profit before tax	21.39	(1.61)	(0.56)	(1.43)	(1.56)	0.48	0.95
Net profit	(4.79)	(1.60)	(0.53)	(1.26)	(1.54)	0.32	0.52
Net profit margin	-10.2%	-6.6%	-1.7%	-4.6%	-13.1%	+2.0%	+2.6%
EPS (₹)	25.74	(2.33)	(0.76)	(1.84)	(2.27)	0.46	0.79
Balance sheet
Total assets	23.44	8.97	10.67	11.26	12.24	13.93	14.06
Net worth	22.10	8.74	10.30	10.81	12.06	13.66	13.41
Total debt	1.12	0.01	0.14	0.27	0.03	0.05	0.08
Cash & bank	10.99	0.36	0.63	0.69	0.22	0.38	0.15
Net working capital	20.14	(4.39)	(2.82)	(2.13)	(0.55)	0.75	0.55
Cash flow
Cash from operations	21.56	(2.55)	0.11	0.65	(0.17)	0.25	0.08
Cash from investing	(11.83)	(0.12)	0.00	(0.01)	0.00	0.00	0.00
Cash from financing	0.89	(0.15)	(0.16)	(0.16)	0.00	(0.02)	(0.11)

Particulars	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024
Revenue	8.28	7.73	16.05	16.55	6.87	5.43	4.72	5.93
Revenue growth (YoY)	+20.5%	+42.4%	+240.0%	+179.1%	-17.1%	-	-	-
Other income	0.30	0.34	19.16	0.14	0.32	0.18	0.19	0.22
Total expenses	8.24	8.40	15.21	14.94	6.78	6.05	5.52	6.71
EBITDA	0.04	(0.67)	0.84	1.61	0.09	(0.62)	(0.80)	(0.78)
EBITDA margin	+0.5%	-8.7%	+5.2%	+9.7%	+1.3%	-11.4%	-16.9%	-13.2%
Depreciation	0.03	0.04	0.06	0.05	0.06	0.08	0.08	0.08
Interest	0.01	0.18	0.02	0.00	0.03	0.00	0.01	0.00
Profit before tax	0.30	(0.55)	19.92	1.70	0.32	(0.52)	(0.70)	(0.64)
Tax	(0.03)	0.17	3.64	(0.04)	0.04	0.01	0.01	0.00

Financial Statements

Figures in ₹ Cr; negatives in brackets. Updated 13 Nov 2026

Particulars	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024
Revenue	8.28	7.73	16.05	16.55	6.87	5.43	4.72	5.93
Revenue growth (YoY)	+20.5%	+42.4%	+240.0%	+179.1%	-17.1%	-	-	-
Other income	0.30	0.34	19.16	0.14	0.32	0.18	0.19	0.22
Total expenses	8.24	8.40	15.21	14.94	6.78	6.05	5.52	6.71
EBITDA	0.04	(0.67)	0.84	1.61	0.09	(0.62)	(0.80)	(0.78)
EBITDA margin	+0.5%	-8.7%	+5.2%	+9.7%	+1.3%	-11.4%	-16.9%	-13.2%
Depreciation	0.03	0.04	0.06	0.05	0.06	0.08	0.08	0.08
Interest	0.01	0.18	0.02	0.00	0.03	0.00	0.01	0.00
Profit before tax	0.30	(0.55)	19.92	1.70	0.32	(0.52)	(0.70)	(0.64)
Tax	(0.03)	0.17	3.64	(0.04)	0.04	0.01	0.01	0.00

Particulars	FY 2025-26	FY 2024-25	FY 2023-24	FY 2022-23	FY 2021-22	FY 2020-21	FY 2019-20
Revenue	47.21	24.37	30.59	27.49	11.77	16.26	19.93
Revenue growth	+93.7%	-20.3%	+11.3%	+133.6%	-27.6%	-18.4%	-
Other income	19.95	0.75	0.66	0.52	0.47	0.89	0.58
Total expenses	45.34	26.39	31.43	29.04	13.51	16.32	19.12
Employee cost	2.61	1.68	1.53	1.41	1.23	1.36	1.40
EBITDA	1.87	(2.02)	(0.84)	(1.55)	(1.74)	(0.06)	0.81
EBITDA margin	+4.0%	-8.3%	-2.8%	-5.6%	-14.8%	-0.4%	+4.1%
Depreciation	0.21	0.32	0.34	0.36	0.29	0.34	0.40
Interest	0.22	0.02	0.04	0.04	0.00	0.01	0.04
Profit before tax	21.39	(1.61)	(0.56)	(1.43)	(1.56)	0.48	0.95
Tax	3.81	(0.01)	(0.03)	(0.17)	(0.02)	0.16	0.43
Net profit	(4.79)	(1.60)	(0.53)	(1.26)	(1.54)	0.32	0.52
Net profit margin	-10.2%	-6.6%	-1.7%	-4.6%	-13.1%	+2.0%	+2.6%
EPS (₹)	25.74	(2.33)	(0.76)	(1.84)	(2.27)	0.46	0.79

Particulars	FY 2025-26	FY 2024-25	FY 2023-24	FY 2022-23	FY 2021-22	FY 2020-21	FY 2019-20
Equity & liabilities
Share capital	6.83	6.83	6.83	6.83	6.83	6.83	6.83
Reserves & surplus	15.27	1.91	3.47	3.98	5.23	6.83	6.58
Shareholders' funds (net worth)	22.10	8.74	10.30	10.81	12.06	13.66	13.41
Secured loans	0.00	0.00	0.00	0.00	0.01	0.02	0.03
Unsecured loans	1.12	0.01	0.14	0.27	0.02	0.03	0.05
Total debt	1.12	0.01	0.14	0.27	0.03	0.05	0.08
Total liabilities	-	-	10.67	11.26	12.24	13.93	14.06
Assets
Gross block	4.65	15.70	15.53	15.40	15.12	15.12	15.12
Net block	1.06	12.33	12.48	12.79	12.76	13.05	13.40
Capital work in progress	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Investments	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Inventories	4.36	3.06	8.50	6.36	4.24	2.63	6.08
Sundry debtors	5.13	3.11	8.05	7.51	3.19	4.27	12.32
Cash & bank balances	10.99	0.36	0.63	0.69	0.22	0.38	0.15
Loans & advances	6.26	1.68	0.79	0.48	0.65	1.31	1.38
Total current assets	26.74	8.21	17.97	15.04	8.30	8.59	19.93
Total current liabilities	6.60	12.60	20.79	17.17	8.85	7.84	19.38
Net working capital	20.14	(4.39)	(2.82)	(2.13)	(0.55)	0.75	0.55
Total assets	23.44	8.97	10.67	11.26	12.24	13.93	14.06

Particulars	FY 2025-26	FY 2024-25	FY 2023-24	FY 2022-23	FY 2021-22	FY 2020-21	FY 2019-20
Opening cash	0.36	0.63	0.69	0.22	0.38	0.15	0.19
Net cash from operating activities	21.56	(2.55)	0.11	0.65	(0.17)	0.25	0.08
Net cash from investing activities	(11.83)	(0.12)	0.00	(0.01)	0.00	0.00	0.00
Net cash from financing activities	0.89	(0.15)	(0.16)	(0.16)	0.00	(0.02)	(0.11)
Net change in cash	10.62	(2.81)	(0.06)	0.48	(0.17)	0.23	(0.03)
Closing cash	10.99	0.36	0.63	0.69	0.22	0.38	0.15

Particulars	FY 2025-26	FY 2024-25	FY 2023-24	FY 2022-23	FY 2021-22	FY 2020-21	FY 2019-20
Growth
Sales growth	+93.7%	-20.3%	+11.3%	+133.6%	-27.6%	-18.4%	-
EBITDA growth	+192.6%	-140.5%	+45.8%	+10.9%	-2800.0%	-107.4%	-
PBT growth	+9998.0%	-187.5%	+60.8%	+8.3%	-	-49.5%	+14.5%
Net income growth	-199.4%	-201.9%	+57.9%	+18.2%	-581.3%	-38.5%	-
Revenue CAGR (3Y)	+19.8%	+27.5%	+23.5%	+11.3%	-21.4%	-5.0%	+11.6%
EBITDA CAGR (3Y)	-	+5.1%	+141.0%	-	-	-	+84.0%
Profitability & leverage
Net income margin	+37.2%	-6.6%	-1.7%	-4.6%	-13.1%	+2.0%	+2.6%
Return on capital employed	+18.6%	0.0%	0.0%	0.0%	-17.8%	+5.0%	+10.4%
Return on net worth	-36.1%	0.0%	0.0%	0.0%	-18.0%	+3.3%	+6.1%
Debt / equity	0.04	0.01	0.03	0.02	0.00	0.01	0.02
Long-term debt / equity	0.00	0.00	0.01	0.01	0.00	0.00	0.00
Interest cover	13.25	-0.85	-3.39	-2.09	0.00	-2.50	9.76
Efficiency & per share
Fixed asset turnover	5.86	2.14	2.73	2.49	1.08	1.49	1.83
Inventory turnover	12.73	4.22	4.12	5.19	3.43	3.73	3.31
Debtors turnover	11.46	4.37	3.93	5.14	3.16	1.96	1.66
EPS (₹)	25.74	(2.33)	(0.76)	(1.84)	(2.27)	0.46	0.79
Dividend per share (₹)	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Book value per share (₹)	32.37	6.58	8.87	9.62	11.45	13.79	13.43

Top companies in Traditional Health & Nutrition

3 companies that operate in the same segment as Phaarmasia (Traditional Health & Nutrition) in India, ranked by their profile score on The Company Check.

Company	Description	Founded	Location	Total funding	Revenue	Employees
Inventia Healthcare	Oral solid drug delivery systems are manufactured and developed.	1985	Mumbai, Maharashtra, India	USD 42.49 M	USD 72.52 M	1,115
Strides Pharma Science	Generic, semi-solid, and liquid dosage forms are manufactured.	1990	Bengaluru, Karnataka, India		USD 508.93 M	4,050
Sun Pharma	Specialty generic pharmaceuticals and APIs are manufactured and marketed.	1983	Mumbai, Maharashtra, India		USD 6.44 B	19,801

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.

Included in your Premium account

✓
Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
✓
Full access to every database India & global coverage, advanced filters and rich profile details
✓
Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Phaarmasia

Where is Phaarmasia located?

Phaarmasia is headquartered in India.

How many employees does Phaarmasia have?

Phaarmasia has 14 employees.

What is the annual revenue of Phaarmasia?

The primary company behind Phaarmasia, Phaarmasia Limited, reported revenue of ₹67.16 Cr for FY 2026, up 94% year on year.

What does Phaarmasia do?

Is Phaarmasia publicly traded?

Yes, Phaarmasia is publicly traded on BSE under the ticker symbol PHRMASI.

Which legal entities are associated with Phaarmasia?

Phaarmasia operates through Phaarmasia Limited.

Who are the directors of Phaarmasia?

The legal entities of Phaarmasia currently have 8 directors, including Maneesh Ramakant Sapte, Eswara Prasad Rao Nagineni, Naga Bhaskarrao Yallapragada and others.